首页> 外国专利> Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent

Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent

机译:单核细胞增生李斯特菌的新型突变株及其在生产IgM抗体中的用途以及作为免疫治疗剂的用途

摘要

A novel mutant strain of Listeria monocytogenes, termed by me "Listeria monocytogenes akka", has been discovered which functions as a killed strain not only as an antigen resulting in the production of relatively large titers of IgM antibodies in host animals but also as an immunopotentiating agent when conjugated to a sensitising antigen, for example, living tumor cells and herpes simplex virus. The high molecular weight IgM antibodies are readily separated from serum and recovered without loss of appreciable activity. The IgM antibodies can be divided into five subunits of IgG antibodies, of lesser molecular weight, having the same specificity as the IgM immunoglobulins. When the sensitizing antigens conjugated with the Listeria monocytogenes strain of this invention are tumor cells, the conjugate acts as an immunotherapeutic agent effective in cancer immunotherapy.
机译:已经发现一种新的单核细胞增生性李斯特菌突变株,被我称为“单核细胞增生性李斯特氏菌”,它不仅可以杀死抗原,而且可以在宿主动物体内产生较大滴度的IgM抗体,而且还可以起到免疫增强作用。当与敏化抗原(例如活体肿瘤细胞和单纯疱疹病毒)缀合时,该药物可作为药物。高分子量IgM抗体很容易从血清中分离出来并回收,而不会损失明显的活性。 IgM抗体可分为分子量较小,与IgM免疫球蛋白具有相同特异性的IgG抗体的五个亚基。当与本发明的单核细胞增生性李斯特氏菌菌株缀合的致敏抗原是肿瘤细胞时,该缀合物充当对癌症免疫疗法有效的免疫治疗剂。

著录项

  • 公开/公告号US4816253A

    专利类型

  • 公开/公告日1989-03-28

    原文格式PDF

  • 申请/专利权人 LIKHITE;VILAS V.;

    申请/专利号US19850807170

  • 发明设计人 VILAS V. LIKHITE;

    申请日1985-12-10

  • 分类号H61K39/02;C12N1/20;

  • 国家 US

  • 入库时间 2022-08-22 06:28:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号